Peptide record

TPDB93313

iRGD Tumor-homing Peptides modified_plain modified
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB93313
iRGD
Tumor-homing Peptides
Cancer-related peptides
TumorHoPe2.0
modified_plain
Yes
A 9-aa modified tumor-homing peptides peptide sequence curated from TumorHoPe2.0, with an available 3D structural model.
N-terminal: propargylglycine
Sequence
CRGDKPGDC
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
9 reviewed residue count
RGD, CendR Activity
propargylglycine Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Tumor cell, Endothelial cell
Homing
Breast cancer, Ovarian cancer
αvβ3 integrins

Source & Reference

TumorHoPe2.0
TumorHoPe2
iRGD-targeted Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Delivery
2023
Krister J Barkovich et al. Small Sci. 2023 Jun 27 3(8):2300067.

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
A2780 cells, MDA-MB-231 cells
female BALB/c Nu/Nu mice at 4-6 weeks
Synthetic
Physalis mottle virus (PhMV) -like nanoparticles
Additional Detail Fields 3 fields
Physalis mottle virus (PhMV) -like nanoparticles
A2780 cells, MDA-MB-231 cells
female BALB/c Nu/Nu mice at 4-6 weeks